An Original Biomarker for the Risk of Developing Cardiovascular Diseases and Their Complications: Telomere Length

Overview

Journal Toxicol Rep

Date 2021 Mar 18

PMID 33732625

Citations 5

Authors

Natalya A Doroschuk

Anton Yu Postnov

Alexander D Doroschuk

Anastasia I Ryzhkova

Vasily V Sinyov

Marina D Sazonova

Victoria A Khotina

Alexander N Orekhov

Igor A Sobenin

Margarita A Sazonova

Affiliations

Soon will be listed here.

Abstract

Aim: The aim of this work was to study the effect of telomere length in the chromosomes of nuclear blood cells in individuals with coronary heart disease (CHD) on the development of cardiovascular complications (CVC).

Materials And Methods: DNA was isolated from nuclear blood cells of 498 study participants. The telomere length was determined by real-time polymerase chain reaction. The investigation of each sample was repeated three times. Five years after the end of this study, a telephone survey of 119 patients with CHD was conducted in order to obtain data on the presence of CVC.

Results: According to the results obtained, a decrease in telomere length in patients with coronary heart disease increases the risk of subsequent development of cardiovascular complications.

Conclusion: Patients with coronary heart disease with shorter telomeres compared with conventionally healthy study participants had an increased risk of cardiovascular complications within 5 years after telomere analysis.

Citing Articles

Variability of Mitochondrial DNA Heteroplasmy: Association with Asymptomatic Carotid Atherosclerosis.

Sazonova M, Kirichenko T, Ryzhkova A, Sazonova M, Doroschuk N, Omelchenko A Biomedicines. 2024; 12(8).

PMID: 39200332 PMC: 11351276. DOI: 10.3390/biomedicines12081868.

UltraAIGenomics: Artificial Intelligence-Based Cardiovascular Disease Risk Assessment by Fusion of Ultrasound-Based Radiomics and Genomics Features for Preventive, Personalized and Precision Medicine: A Narrative Review.

Saba L, Maindarkar M, Johri A, Mantella L, Laird J, Khanna N Rev Cardiovasc Med. 2024; 25(5):184.

PMID: 39076491 PMC: 11267214. DOI: 10.31083/j.rcm2505184.

Biomarkers selection and mathematical modeling in biological age estimation.

Bafei S, Shen C NPJ Aging. 2023; 9(1):13.

PMID: 37393295 PMC: 10314900. DOI: 10.1038/s41514-023-00110-8.

A Unified Model of Age-Related Cardiovascular Disease.

Fossel M, Bean J, Khera N, Kolonin M Biology (Basel). 2022; 11(12).

PMID: 36552277 PMC: 9775230. DOI: 10.3390/biology11121768.

Higher Daily Air Temperature Is Associated with Shorter Leukocyte Telomere Length: KORA F3 and KORA F4.

Ni W, Wolf K, Breitner S, Zhang S, Nikolaou N, Ward-Caviness C Environ Sci Technol. 2022; 56(24):17815-17824.

PMID: 36442845 PMC: 9775210. DOI: 10.1021/acs.est.2c04486.

References

Boyce G, Shoeb M, Kodali V, Meighan T, Roach K, McKinney W . Welding fume inhalation exposure and high-fat diet change lipid homeostasis in rat liver. Toxicol Rep. 2020; 7:1350-1355. PMC: 7569188. DOI: 10.1016/j.toxrep.2020.10.008. View

Cinegaglia N, Antoniazzi L, Rosa D, Miranda D, Acosta-Navarro J, Bortolotto L . Shortening telomere is associated with subclinical atherosclerosis biomarker in omnivorous but not in vegetarian healthy men. Aging (Albany NY). 2019; 11(14):5070-5080. PMC: 6682516. DOI: 10.18632/aging.102098. View

Aviv A, Levy D . Telomeres, atherosclerosis, and the hemothelium: the longer view. Annu Rev Med. 2011; 63:293-301. PMC: 4707036. DOI: 10.1146/annurev-med-050311-104846. View

Petrie J, Guzik T, Touyz R . Diabetes, Hypertension, and Cardiovascular Disease: Clinical Insights and Vascular Mechanisms. Can J Cardiol. 2018; 34(5):575-584. PMC: 5953551. DOI: 10.1016/j.cjca.2017.12.005. View

Sazonova M, Chicheva M, Zhelankin A, Sobenin I, Bobryshev Y, Orekhov A . Association of mutations in the mitochondrial genome with the subclinical carotid atherosclerosis in women. Exp Mol Pathol. 2015; 99(1):25-32. DOI: 10.1016/j.yexmp.2015.04.003. View

Cevik B, Mance-Calisir O, Atbasoglu E, Saka M, Alptekin K, Ucok A . Psychometric liability to psychosis and childhood adversities are associated with shorter telomere length: A study on schizophrenia patients, unaffected siblings, and non-clinical controls. J Psychiatr Res. 2019; 111:169-185. DOI: 10.1016/j.jpsychires.2019.01.022. View

Epel E, Blackburn E, Lin J, Dhabhar F, Adler N, Morrow J . Accelerated telomere shortening in response to life stress. Proc Natl Acad Sci U S A. 2004; 101(49):17312-5. PMC: 534658. DOI: 10.1073/pnas.0407162101. View

Zhelankin A, Sazonova M . [Association of the mutations in the human mitochondrial genome with chronic non-inflammatory diseases: type 2 diabetes, hypertension and different types of cardiomyopathy]. Patol Fiziol Eksp Ter. 2012; (3):123-8. View

Hajibabaie F, Kouhpayeh S, Mirian M, Rahimmanesh I, Boshtam M, Sadeghian L . MicroRNAs as the actors in the atherosclerosis scenario. J Physiol Biochem. 2019; 76(1):1-12. DOI: 10.1007/s13105-019-00710-7. View

10.

Sharifi-Rad M, Anil Kumar N, Zucca P, Varoni E, Dini L, Panzarini E . Lifestyle, Oxidative Stress, and Antioxidants: Back and Forth in the Pathophysiology of Chronic Diseases. Front Physiol. 2020; 11:694. PMC: 7347016. DOI: 10.3389/fphys.2020.00694. View

11.

Nelson C, Codd V . Genetic determinants of telomere length and cancer risk. Curr Opin Genet Dev. 2020; 60:63-68. DOI: 10.1016/j.gde.2020.02.007. View

12.

Kalstad A, Tveit S, Myhre P, Laake K, Opstad T, Tveit A . Leukocyte telomere length and serum polyunsaturated fatty acids, dietary habits, cardiovascular risk factors and features of myocardial infarction in elderly patients. BMC Geriatr. 2019; 19(1):376. PMC: 6935134. DOI: 10.1186/s12877-019-1383-9. View

13.

Kordinas V, Ioannidis A, Chatzipanagiotou S . The Telomere/Telomerase System in Chronic Inflammatory Diseases. Cause or Effect?. Genes (Basel). 2016; 7(9). PMC: 5042391. DOI: 10.3390/genes7090060. View

14.

Qian W, Kumar N, Roginskaya V, Fouquerel E, Opresko P, Shiva S . Chemoptogenetic damage to mitochondria causes rapid telomere dysfunction. Proc Natl Acad Sci U S A. 2019; 116(37):18435-18444. PMC: 6744920. DOI: 10.1073/pnas.1910574116. View

15.

Smith E, Pendlebury D, Nandakumar J . Structural biology of telomeres and telomerase. Cell Mol Life Sci. 2019; 77(1):61-79. PMC: 6986361. DOI: 10.1007/s00018-019-03369-x. View

16.

Ryzhkova A, Sazonova M, Sinyov V, Galitsyna E, Chicheva M, Melnichenko A . Mitochondrial diseases caused by mtDNA mutations: a mini-review. Ther Clin Risk Manag. 2018; 14:1933-1942. PMC: 6186303. DOI: 10.2147/TCRM.S154863. View

17.

Dai D, Chiao Y, Marcinek D, Szeto H, Rabinovitch P . Mitochondrial oxidative stress in aging and healthspan. Longev Healthspan. 2014; 3:6. PMC: 4013820. DOI: 10.1186/2046-2395-3-6. View

18.

Zhang Y, Guo Y, Zhou G, Li S . Regulation of Telomere Length and Atherosclerosis by Protection of Telomeres 1 Protein. J Nanosci Nanotechnol. 2019; 19(12):7953-7959. DOI: 10.1166/jnn.2019.16938. View

19.

Islam M . Oxidative stress and mitochondrial dysfunction-linked neurodegenerative disorders. Neurol Res. 2016; 39(1):73-82. DOI: 10.1080/01616412.2016.1251711. View

20.

Jiangpan P, Qingsheng M, Zhiwen Y, Tao Z . Emerging Role of microRNA in Neuropathic Pain. Curr Drug Metab. 2015; 17(4):336-44. DOI: 10.2174/1389200216666151015113400. View